A new test for cervical cancer was found to detect all of the cancers in a randomised clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, according to a study led by Queen Mary University of London.
The study, published in the International Journal of Cancer, compared a new ‘epigenetics-based’ cervical cancer test with Pap smear and HPV tests, and investigated how well it predicted the development of cervical cancer up to five years in advance in a large study of women aged 25-65 in Canada.
As opposed to checking for patterns in the DNA genetic code itself that are indicative of the HPV virus, the new test looks at the naturally-occurring chemical markers that appear on top of the DNA, making up its ‘epigenetic profile’.
‘An enormous development’
Lead researcher Professor Attila Lorincz from Queen Mary’s Wolfson Institute of Preventive Medicine who also helped develop the world’s first test for HPV in 1988, said: “This is an enormous development. We’re not only astounded by how well this test detects cervical cancer, but it is the first time that anyone has proven the key role of epigenetics in the development of a major solid cancer using data from patients in the clinic. Epigenetic changes are what this cervical cancer test picks up and is exactly why it works so well.
“In contrast to what most researchers and clinicians are saying, we are seeing more and more evidence that it is in fact epigenetics, and not DNA mutations, that drives a whole range of early cancers, including cervical, anal, oropharyngeal, colon, and prostate.”
Screening to prevent cervical cancer is typically done through the Pap smear, which involves the collection, staining and microscopic examination of cells from the cervix. Unfortunately, the Pap smear can detect only around 50 per cent of cervical pre-cancers.
A much more accurate cervical screening method involves testing for the presence of DNA from the human papillomavirus (HPV) – the primary but indirect cause of cervical cancer. There are estimated to be around 10 million women in the UK who are infected by HPV.
However, the HPV test only identifies whether or not women are infected with a cancer-causing HPV, but not their actual risks of cancer, which remain quite low. This causes unnecessary worry for the majority of HPV-infected women who receive a positive result but will eventually clear the virus and not develop the disease.
Predicting a person’s risk of cervical cancer
The new test was significantly better than either the Pap smear or HPV test. It detected 100 per cent of the eight invasive cervical cancers that developed in the 15,744 women during the trial. In comparison, the Pap smear only detected 25 per cent of the cancers, and the HPV test detected 50 per cent.
The study also looked more closely at a subset of 257 HPV-positive women which were representatively selected from the large study. The new test detected 93 per cent of pre-cancerous lesions in those women, compared to 86 per cent detected using a combination of the Pap smear and HPV test, and 61 per cent detected using the Pap smear on its own.
Reducing the number of screening appointments needed
Professor Lorincz added: “This really is a huge advance in how to deal with HPV-infected women and men, numbering in the billions worldwide, and it is going to revolutionise screening.
“We were surprised by how well this new test can detect and predict early cervical cancers years in advance, with 100 per cent of cancers detected, including adenocarcinomas, which is a type of cervical cancer that is very difficult to detect. The new test is much better than anything offered in the UK at present but could take at least five years to be established.”
The authors say that using this test in the clinic would reduce the number of visits to the doctor and screening appointments, as high-grade disease would be detected from the start. They also say that if it was fully implemented, it would be cheaper than the Pap smear.
The Latest on: Cervical cancer
via Google News
The Latest on: Cervical cancer
- Cervical cancer screening to resume from Julyon June 24, 2020 at 8:33 am
The HSE has confirmed women identified as a priority for CervicalCheck screening will start receiving letters for an appointment from July 6.
- Grieving mum in smear test plea after daughter dies from cervical cancer at 26on June 24, 2020 at 7:36 am
Lynda Gilling has made an emotional appeal for young women to get a smear test after her daughter Jess Jackson, from Rumney, Cardiff, died on June 12 leaving behind three children ...
- HSE says cervical cancer screening will resume next monthon June 24, 2020 at 7:34 am
The HSE has confirmed that cervical cancer screening will resume next month after being halted due to the Covid-19 pandemic. Cancer-screening services including BreastCheck, CervicalCheck as well as ...
- Mum-of-three dies of cervical cancer at 26 as her heartbroken family pleads for young women to attend screeningson June 24, 2020 at 6:12 am
Heartfelt tributes have been paid to a mum-of-three who has died of cervical cancer at the age of just 26. Jess Jackson, described as a "beautiful lady" and a "massive character", lost her two-year ...
- Tanzania: Govt Committed to Eradicating Cervical Cancer, Says Officialon June 23, 2020 at 6:10 am
He said there were 620 cancer testing health centres countrywide located in all corners for easy access. "We want a cervical cancer free generation that is why we have a number of awareness ...
- Insights on the Cervical Cancer Diagnostic Testing Market to 2027 - Featuring BioVantra, Cancer Genetics & Cepheid Among Otherson June 16, 2020 at 10:15 am
Amid the COVID-19 crisis and the looming economic recession, the Cervical Cancer Diagnostic Testing market worldwide will grow by a projected US$2.3 Billion, during the analysis period, driven by a ...
- Support for cervical cancer screening using Pap and HPV testing together continues to grow among health care providers and womenon June 16, 2020 at 4:30 am
New survey results exploring cervical cancer screening behaviors and attitudes show that a significant majority of health care providers ...
- Taxonomic and Functional Differences in Cervical Microbiome Associated with Cervical Cancer Developmenton June 16, 2020 at 2:09 am
The cervical microbiome is associated with cervical cancer risk, but how microbial diversity and functional profiles change in cervical cancer remains unclear. Herein, we investigated ...
- Antibodies against sugars, internal radiation: Powerful package against cervical canceron June 16, 2020 at 12:40 am
The sugar coating on cancer cells helps them thrive, and a new study indicates patients with cervical cancer who make antibodies to those sugars appear to do better when they also receive internal ...
- New study confirms superiority of open surgery for early-stage cervical canceron June 11, 2020 at 12:45 pm
A study led by researchers at Columbia University Irving Medical Center confirms that minimally invasive surgery for early-stage cervical cancer is linked to higher rates of recurrence and death ...
via Bing News